share_log

HC Wainwright & Co. Maintains Buy on Asensus Surgical, Lowers Price Target to $2

Benzinga ·  Mar 6, 2023 06:08

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and lowers the price target from $3 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment